Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_assertion type Assertion NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_head.
- NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_assertion description "[Since elevated expression levels of the epidermal growth factor receptor (EGF-R), in addition to that of c-Ha-ras, have been correlated with transitional cell carcinoma progression, we sought to determine whether up-regulation of the EGF-R had occurred in the invasive high ras expressors and if so, what functional significance this might have.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_provenance.
- NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_assertion evidence source_evidence_literature NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_provenance.
- NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_assertion SIO_000772 1868471 NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_provenance.
- NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_assertion wasDerivedFrom befree-20140225 NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_provenance.
- NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_assertion wasGeneratedBy ECO_0000203 NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_provenance.